The arrival of oral GLP-1 medications — the Wegovy pill (oral semaglutide 25 mg, approved December 2025) and Foundayo (orforglipron 36 mg, approved April 2026) — has created a new comparison point. For the first time, patients can choose between injectable and oral formats for FDA-approved weight loss medication. But "needle-free" is a marketing claim, not an efficacy claim. Here's what the data shows.
Injectable vs. Oral: Efficacy Numbers
| Medication | Format | Avg Weight Loss | Trial Duration |
|---|---|---|---|
| Wegovy 2.4 mg | Weekly injection | ~15% | 68 weeks |
| Wegovy HD 7.2 mg | Weekly injection | ~17–21% | 68 weeks |
| Wegovy Pill 25 mg | Daily oral | ~13.6–16.6% | 64 weeks |
| Foundayo 36 mg | Daily oral | ~12.4% | 72 weeks |
| Zepbound 15 mg | Weekly injection | ~22.5% | 72 weeks |
The Wegovy pill approaches — but doesn't match — injectable semaglutide efficacy. Foundayo, a different molecule (orforglipron), produces slightly less weight loss but with a major convenience advantage: no food or water restrictions, taken any time of day. Injectable tirzepatide (Zepbound) remains the most effective option by a meaningful margin.
The Convenience vs. Efficacy Tradeoff
Oral semaglutide requires fasting: take it on an empty stomach with no more than 4 oz of water, then wait 30 minutes before eating or drinking anything else. This fasting requirement exists because oral semaglutide has low bioavailability — only about 1% of the drug is absorbed. The 25 mg oral dose delivers roughly equivalent exposure to the 2.4 mg injection, but achieving that requires the fasting protocol.
Foundayo eliminates this constraint entirely. As a small-molecule GLP-1 agonist (not a peptide), it's absorbed normally through the gut without fasting requirements. This is a genuine convenience advantage — but it comes with modestly lower efficacy compared to injectable semaglutide.
If maximum weight loss is your priority, injectable tirzepatide (Zepbound) remains the gold standard. If you want near-equivalent semaglutide efficacy without needles, the Wegovy pill is the closest match — but requires strict fasting. If convenience is paramount and you'll trade some efficacy for flexibility, Foundayo offers the easiest daily routine. There's no wrong answer — the right choice depends on what you'll actually stick with.
Injectable semaglutide. Physician-led protocols, custom metabolic report, HSA/FSA accepted. Fast onboarding.
Brand-name + compounded GLP-1 with coaching and insurance coordination. Over 250K patients.
Sema $99/mo, tirz $133/mo. Free consult, free shipping, no membership. Code x7X72r saves $25.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. All medications require evaluation by a licensed healthcare provider. Compounded medications are not FDA-approved. Individual results vary.